Shingles (Herpes Zoster): Symptoms, Course, and Key Features

Shingles results from reactivation of varicella-zoster virus (VZV) in a dorsal root ganglion. It follows a unilateral dermatomal distribution.

Classic Presentation

  1. Prodrome (1–5 days): Burning, stabbing, or throbbing pain ± itch, paresthesia, headache, photophobia, malaise.
  2. Eruptive phase: Erythematous maculopapular rash → grouped vesicles on erythematous base in a single dermatome (thoracic > trigeminal > lumbar).
  3. Vesicles pustulate → crust over 7–10 days. Healing in 2–4 weeks; may leave hyperpigmentation or scarring.

Key Features

  • Dermatomal distribution: Does not cross midline (unlike disseminated zoster in immunocompromised).
  • Allodynia/hyperesthesia: Light touch (clothing, breeze) causes severe pain.
  • Associated symptoms: Fever, fatigue, headache, nausea.

Complications

  • Postherpetic neuralgia (PHN): pain >90 days after rash onset (10–18% risk, ↑ with age)
  • Herpes zoster ophthalmicus (V1): vision threat—urgent ophthalmology
  • Ramsay Hunt syndrome (geniculate ganglion): facial palsy, ear pain, vesicles
  • Bacterial superinfection, motor weakness, CNS involvement (rare)

Treatment

Antivirals (valacyclovir 1g TID × 7 days) within 72 hrs of rash onset reduce severity and PHN risk. Adjuncts: gabapentin/pregabalin, topical lidocaine, corticosteroids (controversial).

Prevention

Recombinant zoster vaccine (Shingrix) 2 doses ≥50 yrs or ≥19 immunocompromised—>90% efficacy.

Illness - Related Articles